Company / Depreciation & Amortization
IONIS PHARMACEUTICALS INC Depreciation & Amortization History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$12.5M
FY2021
5-year range
$12.5M / $12.5M
FY2018-FY2021
Trend
+17.1%
vs FY2020
Sector context
#58 of 163
Health Care
What the data says
At $13M, IONIS PHARMACEUTICALS INC's depreciation & amortization ranks #106 of 163 in the Health Care sector. Increased from $7M to $13M over the past 2 years.
Based on SEC 10-K filings.
$13M in FY2021 with a 3-year CAGR of +18.8%.
Increased from $7M to $13M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +18.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 163 in Health CareTop 64% of 163This company $12.5M Sector average $219.4M
▼
-94.3% below sector average
Key checks
Key Insights
- 3-year CAGR of +18.8%, indicating consistent growth.
- In FY2021, depreciation & amortization increased 17.1% year-over-year.
- Ranks #58 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $12.5M | +17.1% |
| FY2020 | $10.7M | +59.6% |
| FY2019 | $6.7M | -10.3% |
| FY2018 | $7.5M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026